Citations (30)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (6)
Keita Inui, Naoki Sawa, Tatsuya Suwabe, Hiroki Mizuno, Masayuki Yamanouchi, Rikako Hiramatsu, Noriko Hayami, Junichi Hoshino, Keiichi Kinowaki, Takeshi Fujii, Kenichi Ohashi & Yoshifumi Ubara. (2020) Long term administration of tocilizumab improves renal amyloid A (AA) amyloidosis deposition in Familial Mediterranean fever. Modern Rheumatology Case Reports 4:2, pages 310-311.
Read now
Read now
Satoshi Hamanoue, Tatsuya Suwabe, Junichi Hoshino, Keiichi Sumida, Koki Mise, Noriko Hayami, Naoki Sawa, Kenmei Takaichi, Takeshi Fujii, Kenichi Ohashi, Masahide Yazaki, Shuichi Ikeda & Yoshifumi Ubara. (2016) Successful treatment with humanized anti–interleukin-6 receptor antibody (tocilizumab) in a case of AA amyloidosis complicated by familial Mediterranean fever. Modern Rheumatology 26:4, pages 610-613.
Read now
Read now
Alice Courties, Gilles Grateau, Peggy Philippe, René-Marc Flipo, Leonardo Astudillo, Bérengère Aubry-Rozier, Isabelle Fabreguet, Wafki Fahd, Olivier Fain, Pascal Guggenbuhl, Eric Hachulla, Thomas Papo, Christophe Richez, Jean Sibilia, Jacques Morel, Francis Berenbaum & Jérémie Sellam. (2015) AA amyloidosis treated with tocilizumab: case series and updated literature review. Amyloid 22:2, pages 84-92.
Read now
Read now
Shuzo Yoshida, Tohru Takeuchi, Hideaki Sawaki, Tamaki Imai, Shigeki Makino & Toshiaki Hanafusa. (2014) Successful treatment with tocilizumab of pericarditis associated with rheumatoid arthritis. Modern Rheumatology 24:4, pages 677-680.
Read now
Read now
Alojzija Hočevar, Boris Lestan, Snežna Sodin Šemrl, Katja Lakota, Nika Kojc, Nataša Potočnik & Matija Tomšič. (2013) AA amyloidosis in a polyarteritis nodosa patient treated with tocilizumab. Amyloid 20:4, pages 275-276.
Read now
Read now
Rieke Alten & Tazio Maleitzke. (2013) Tocilizumab: A novel humanized anti-interleukin 6 (IL-6) receptor antibody for the treatment of patients with non-RA systemic, inflammatory rheumatic diseases. Annals of Medicine 45:4, pages 357-363.
Read now
Read now
Articles from other publishers (24)
Semih Gülle, Ömer Komaç, Gerçek Can & Fatoş Önen. (2023) A rare condition in Takayasu arteritis: Renal amyloidosis. Archives of Rheumatology 38:4, pages 653-655.
Crossref
Crossref
Paula Kilić, Lucija Ikić, Miroslav Mayer, Marinko Artuković, Ksenija Maštrović Radončić & Marina Ikić Matijašević. (2023) Safe and Efficient Use of Tocilizumab in Rheumatoid Arthritis Patient on Maintenance Hemodialysis: A Case Report. Medicina 59:9, pages 1517.
Crossref
Crossref
Sandra M. Ihne-Schubert, Malte Kircher, Rudolf A. Werner, Constantin Lapa, Hermann Einsele, Andreas Geier & Torben Schubert. (2023) Vector autoregression: Useful in rare diseases?—Predicting organ response patterns in a rare case of secondary AA amyloidosis. PLOS ONE 18:8, pages e0289921.
Crossref
Crossref
Sabine Karam, Mohamad Haidous, Virginie Royal & Nelson Leung. (2023) Renal AA amyloidosis: presentation, diagnosis, and current therapeutic options: a review. Kidney International 103:3, pages 473-484.
Crossref
Crossref
Kanako Imamura, Sunao Kojima, Takahisa Imamura & Kenichi Tsujita. (2022) Recovery from AA amyloidosis-cardiomyopathy complexed with unicentric Castleman disease. BMJ Case Reports 15:8, pages e250338.
Crossref
Crossref
Jacques Morel, Anne Tournadre, Jérémie Sellam, Yoram Bouhnik, Divi Cornec, Valérie Devauchelle-Pensec, Philippe Dieudé, Philippe Goupille, Nicolas Kluger, Estibaliz Lazaro, Benoit Le Goff, Victor de Lédinghen, Thierry Lequerré, Gaëtane Nocturne, Raphaèle Seror, Marie-Elise Truchetet, Frank Verhoeven, Thao Pham & Christophe Richez. (2021) Practical management of patients on anti-IL6R therapy: Practical guidelines drawn up by the Club Rhumatismes et Inflammation (CRI). Joint Bone Spine 88:4, pages 105221.
Crossref
Crossref
Ju-Yang Jung, Young-Bae Kim, Ji-won Kim, Chang-Hee Suh & Hyoun-Ah Kim. (2021) Biologic therapy for amyloid A amyloidosis secondary to rheumatoid arthritis treated with interleukin 6 therapy. Medicine 100:32, pages e26843.
Crossref
Crossref
Masato Sawamura, Naoki Sawa, Hideomi Fujiwara, Masayuki Yamanouchi, Noriko Hayami, Akinari Sekine, Hiroki Mizuno, Eiko Hasegawa, Tatsuya Suwabe, Junichi Hoshino, Keiichi Kinowaki, Takeshi Fujii & Yoshifumi Ubara. (2020) Abatacept Improves Intractable Protein-Losing Enteropathy Secondary to AA Amyloidosis in a Patient With Rheumatoid Arthritis. Mayo Clinic Proceedings: Innovations, Quality & Outcomes 4:6, pages 815-820.
Crossref
Crossref
Sawa Miyagawa, Tadashi Miyamoto & Yukihito Sato. (2020) Soluble tumour necrosis factor-alpha receptor improved the function, hypertrophy, and granular sparkling appearance of the left ventricular myocardium in systemic amyloid A amyloidosis: a case report. European Heart Journal - Case Reports 4:3, pages 1-7.
Crossref
Crossref
Dosuke Iwadate, Eiko Hasegawa, Junichi Hoshino, Noriko Hayami, Keiichi Sumida, Masayuki Yamanouchi, Akinari Sekine, Masahiro Kawada, Rikako Hiramatsu, Tatsuya Suwabe, Naoki Sawa, Mitsuhiro Yuasa, Atsushi Wake, Takeshi Fujii, Kenichi Ohashi, Kenmei Takaichi & Yoshifumi Ubara. (2018) The Long-term Outcomes after VAD plus SCT Therapy in a Patient with AL Amyloidosis and Severe Factor X Deficiency. Internal Medicine 57:5, pages 701-706.
Crossref
Crossref
Katia Stankovic Stojanovic, Sophie Georgin-Lavialle & Gilles Grateau. (2017) Amylose AA. Néphrologie & Thérapeutique 13:4, pages 258-264.
Crossref
Crossref
Sunita Paudyal, Frances M. Yang, Christopher Rice, Chen-Chun Chen, Michael Skelton, Monique Bethel, Shilpa Brown, Norris Stanley NahmanJrJr & Laura Carbone. (2017) End-stage renal disease in patients with rheumatoid arthritis. Seminars in Arthritis and Rheumatism 46:4, pages 418-422.
Crossref
Crossref
Rekha Mankad, Carolyn A Ball, Elena Myasoedova & Eric L Matteson. 2017. Handbook of Cardiovascular Disease Management in Rheumatoid Arthritis. Handbook of Cardiovascular Disease Management in Rheumatoid Arthritis
19
38
.
Toshiharu Ueno, Keiichi Sumida, Junichi Hoshino, Tatsuya Suwabe, Koki Mise, Ryo Hazue, Noriko Hayami, Rikako Hiramatsu, Masahiro Kawada, Aya Imafuku, Eiko Hasegawa, Naoki Sawa, Kenmei Takaichi, Keiichi Kinowaki, Kenichi Ohashi, Takeshi Fujii, Aya Nishida & Yoshifumi Ubara. (2016) AA-negative and Kappa-positive Amyloidosis in a Patient with Rheumatoid Arthritis. Internal Medicine 55:17, pages 2491-2495.
Crossref
Crossref
Traci L. Parry, Jason H. Melehani, Mark J. Ranek & Monte S. Willis. (2015) Functional Amyloid Signaling via the Inflammasome, Necrosome, and Signalosome: New Therapeutic Targets in Heart Failure. Frontiers in Cardiovascular Medicine 2.
Crossref
Crossref
Kohsuke Shirakawa, Toru Egashira, Masaki Ieda, Shinji Kawaguchi, Kazuma Okamoto, Mikihiko Kudo, Kenji Yokoyama, Hikaru Tsuruta, Mitsushige Murata, Shuji Mikami, Atsushi Anzai, Kentaro Hayashida, Takashi Kohno, Yuichiro Maekawa, Motoaki Sano, Ryohei Yozu & Keiichi Fukuda. (2014) Multidisciplinary approach to the treatment of cardiac AA amyloidosis and aortic stenosis due to Castleman's disease: A hybrid therapy with tocilizumab and aortic valve replacement. International Journal of Cardiology 173:2, pages e9-e11.
Crossref
Crossref
Kei Nagai, Atsushi Ueda & Kunihiro Yamagata. (2014) Successful Use of Tocilizumab in a Case of Multicentric Castleman's Disease and End-Stage Renal Disease. Therapeutic Apheresis and Dialysis 18:2, pages 210-211.
Crossref
Crossref
Masaru Matsui, Satoshi Okayama, Hideo Tsushima, Kenichi Samejima, Tomoko Kanki, Ayako Hasegawa, Katsuhiko Morimoto, Yasuhiro Akai, Masato Takano, Shiro Uemura, Chiho Ohbayashi & Yoshihiko Saito. (2014) Therapeutic Benefits of Tocilizumab Vary in Different Organs of a Patient with AA Amyloidosis. Case Reports in Nephrology 2014, pages 1-6.
Crossref
Crossref
Bożena Targońska-Stępniak & Maria Majdan. (2014) Serum Amyloid A as a Marker of Persistent Inflammation and an Indicator of Cardiovascular and Renal Involvement in Patients with Rheumatoid Arthritis. Mediators of Inflammation 2014, pages 1-7.
Crossref
Crossref
Sophie Mavrogeni, Theodoros Dimitroulas, Petros P. Sfikakis & George D. Kitas. (2013) Heart involvement in rheumatoid arthritis: Multimodality imaging and the emerging role of cardiac magnetic resonance. Seminars in Arthritis and Rheumatism 43:3, pages 314-324.
Crossref
Crossref
A. Cañas-Ventura, E. Rodríguez, M. Andreu & L. Márquez. (2013) Tocilizumab in Amyloidosis-Associated Kidney Disease Secondary to Inflammatory Bowel Diseases. Digestive Diseases and Sciences 58:9, pages 2736-2737.
Crossref
Crossref
Toshio Tanaka, Atsushi OgataMasashi Narazaki. (2013) Tocilizumab: An Updated Review of Its Use in the Treatment of Rheumatoid Arthritis and Its Application for Other Immune-Mediated Diseases. Clinical Medicine Insights: Therapeutics 5, pages CMT.S9282.
Crossref
Crossref
Shuzo Yoshida, Tohru Takeuchi, Hideaki Sawaki, Tamaki Imai, Shigeki Makino & Toshiaki Hanafusa. (2012) Successful treatment with tocilizumab of pericarditis associated with rheumatoid arthritis. Modern Rheumatology.
Crossref
Crossref
Daniel Bunker & Peter Gorevic. (2012) AA Amyloidosis: Mount Sinai Experience, 1997–2012. Mount Sinai Journal of Medicine: A Journal of Translational and Personalized Medicine 79:6, pages 749-756.
Crossref
Crossref